Medtech startups hear dour diagnosis

Medtech startups hear dour diagnosis - by Rick Merritt, EETimes

Here’s another angle on the BIOMEDevice Conference that I wrote about a few days ago, which expands on the points about regulation and VC investment trends.

- Ken

Leave a Comment

You must be logged in to post a comment.